Urinary tract infection of mice to model human disease: Practicalities, implications and limitations

References

• Agace WW. (1996). The role of the epithelial cell in Escherichia coli induced neutrophil migration into the urinary tract. Eur Respir J 9:1713–28
   PubMed Web of Science ®Google Scholar
• Agace WW, Hedges SR, Ceska M, Svanborg C. (1993). Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 92:780–5
   PubMed Web of Science ®Google Scholar
• Akil I, Ozkinay F, Onay H, et al. (2012). Assessment of toll-like receptor-4 gene polymorphism on pyelonephritis and renal scar. Int J Immunogenet 39:303–7
   PubMed Web of Science ®Google Scholar
• Alamuri P, Eaton KA, Himpsl SD, et al. (2009). Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun 77:632–41
   PubMed Web of Science ®Google Scholar
• Allsopp LP, Beloin C, Ulett GC, et al. (2012). Molecular characterization of UpaB and UpaC two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 80:321–32
   PubMed Web of Science ®Google Scholar
• Allsopp LP, Totsika M, Tree JJ, et al. (2010). UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78:1659–69
   PubMed Web of Science ®Google Scholar
• Alteri CJ, Hagan EC, Sivick KE, et al. (2009a). Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 5:e1000586
   PubMed Web of Science ®Google Scholar
• Alteri CJ, Mobley HL. (2007). Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 75:2679–88
   PubMed Web of Science ®Google Scholar
• Alteri CJ, Smith SN, Mobley HL. (2009b). Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 5:e1000448
   PubMed Web of Science ®Google Scholar
• Andersen-Nissen E, Hawn TR, Smith KD, et al. (2007). Cutting edge: Tlr5−/− mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 178:4717–20
   PubMed Web of Science ®Google Scholar
• Anderson GG, Goller CC, Justice S, et al. (2010). Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun 78:963–75
   PubMed Web of Science ®Google Scholar
• Anderson GG, Palermo JJ, Schilling JD, et al. (2003). Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105–7
   PubMed Web of Science ®Google Scholar
• Armbruster CE, Smith SN, Yep A, Mobley HL. (2014). Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis 209:1524–32
   PubMed Web of Science ®Google Scholar
• Artifoni L, Negrisolo S, Montini G, et al. (2007). Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol 177:1102–6
   PubMed Web of Science ®Google Scholar
• Asadi Karam MR, Oloomi M, Mahdavi M, et al. (2013). Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31:1210–16
   PubMed Web of Science ®Google Scholar
• Baier W, Sedelmeier EA, Bessler WG. (1997). Studies on the immunogenicity of an Escherichia coli extract after oral application in mice. Arzneim-Forsch 47:980–5
   PubMed Web of Science ®Google Scholar
• Bala A, Chhibber S, Harjai K. (2014). Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa. Int J Med Microbiol 304:1199--208
   PubMed Web of Science ®Google Scholar
• Barbieri NL, Nicholson B, Hussein A, et al. (2014). FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli. Infect Immun 82:5086–98
   PubMed Web of Science ®Google Scholar
• Barnett BJ, Stephens DS. (1997). Urinary tract infection: an overview. Am J Med Sci 314:245–9
   PubMed Web of Science ®Google Scholar
• Bates JM, Raffi HM, Prasadan K, et al. (2004). Tamm–Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791–7
   PubMed Web of Science ®Google Scholar
• Bessler WG, Puce K, Vor Dem Esche U, et al. (2009). Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes. Arzneim-Forsch 59:571–7
   PubMed Web of Science ®Google Scholar
• Bessler WG, Vor Dem Esche U, Zgaga-Griesz A, Ataullakhanov R. (2010). Immunostimulatory properties of the bacterial extract OM-89 in vitro and in vivo. Arzneim-Forsch 60:324–9
   PubMed Web of Science ®Google Scholar
• Bielecki P, Muthukumarasamy U, Eckweiler D, et al. (2014). In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. MBio 5:e01075–14
   PubMed Web of Science ®Google Scholar
• Billips BK, Forrestal SG, Rycyk MT, et al. (2007). Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 75:5353–60
   PubMed Web of Science ®Google Scholar
• Blango MG, Mulvey MA. (2010). Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855–63
   PubMed Web of Science ®Google Scholar
• Bokil NJ, Totsika M, Carey AJ, et al. (2011). Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology 216:1164–71
   PubMed Web of Science ®Google Scholar
• Bolton M, Horvath DJ Jr, Li B, et al. (2012). Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis. PLoS One 7:e33897
   PubMedGoogle Scholar
• Bosch A, Benedi VJ, Pares R, Jofre J. (1988). Enhancement of the humoral immune response and resistance to bacterial infection in mice by the oral administration of a bacterial immunomodulator (OM-89). Immunopharm Immunotoxicol 10:333–43
   PubMed Web of Science ®Google Scholar
• Bower JM, Eto DS, Mulvey MA. (2005). Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6:18–31
   PubMed Web of Science ®Google Scholar
• Brown PD. (1999). Antibiotic selection for urinary tract infection: new microbiologic considerations. Cur Infect Dis Rep 1:384–8
   PubMedGoogle Scholar
• Brumbaugh AR, Mobley HL. (2012). Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 11:663–76
   PubMed Web of Science ®Google Scholar
• Brumbaugh AR, Smith SN, Mobley HL. (2013). Immunization with the yersiniabactin receptor, FyuA protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun 81:3309–16
   PubMed Web of Science ®Google Scholar
• Candela JV, Park E, Gerspach JM, et al. (1998). Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria. Urol Res 26:175–80
   PubMedGoogle Scholar
• Chan CY, St John AL, Abraham SN. (2013). Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38:349–59
   PubMed Web of Science ®Google Scholar
• Chassin C, Goujon JM, Darche S, et al. (2006). Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol 177:4773–84
   PubMed Web of Science ®Google Scholar
• Chassin C, Hornefm W, Bens M, et al. (2007). Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J Exp Med 204:2837–52
   PubMed Web of Science ®Google Scholar
• Chen SL, Hung CS, Pinkner JS, et al. (2009). Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci USA 106:22439–44
   PubMed Web of Science ®Google Scholar
• Chenoweth C, Saint S. (2013). Preventing catheter-associated urinary tract infections in the intensive care unit. Crit Care Clin 29:19–32
   PubMed Web of Science ®Google Scholar
• Chromek M, Slamova Z, Bergman P, et al. (2006). The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636–41
   PubMed Web of Science ®Google Scholar
• Chuang FC, Kuo HC. (2013). Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women. PLoS One 8:e63760
   PubMedGoogle Scholar
• Cirl C, Wieser A, Yadav M, et al. (2008). Subversion of toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14:399–406
   PubMed Web of Science ®Google Scholar
• Cole SJ, Records AR, Orr MW, et al. (2014). Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect Immun 82:2048–58
   PubMed Web of Science ®Google Scholar
• Connell I, Agace W, Klemm P, et al. (1996). Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 93:9827–32
   PubMed Web of Science ®Google Scholar
• Cusumano CK, Pinkner JS, Han Z, et al. (2011). Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med 3:109ra115
   PubMed Web of Science ®Google Scholar
• Danka ES, Hunstad DA. (2015). Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J Infect Dis 211:1164--73
   PubMed Web of Science ®Google Scholar
• Davis PH, Stanley SL Jr. (2003). Breaking the species barrier: use of SCID mouse–human chimeras for the study of human infectious diseases. Cell Microbiol 5:849–60
   PubMed Web of Science ®Google Scholar
• De Man P, Van Kooten C, Aarden L, et al. (1989). Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infect Immun 57:3383–8
   PubMed Web of Science ®Google Scholar
• Deknuydt F, Scotet E, Bonneville M. (2009). Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans? Immunol Lett 127:8–12
   PubMed Web of Science ®Google Scholar
• Dhakal BK, Mulvey MA. (2012). The UPEC pore-forming toxin alpha-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11:58–69
   PubMed Web of Science ®Google Scholar
• Duell BL, Carey AJ, Dando SJ, et al. (2013). Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli. PLoS One 8:e78013
   PubMed Web of Science ®Google Scholar
• Duell BL, Carey AJ, Tan CK, et al. (2012a). Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol 188:781–92
   PubMed Web of Science ®Google Scholar
• Duell BL, Tan CK, Carey AJ, et al. (2012b). Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis. FEMS Immunol Med Microbiol 64:295–313
   PubMedGoogle Scholar
• Fischer H, Lutay N, Ragnarsdottir B, et al. (2010). Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog 6:e1001109
   PubMedGoogle Scholar
• Fischer H, Yamamoto M, Akira S, et al. (2006). Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36:267–77
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Pinkner JS, Caparon MG, Hultgren SJ. (2014). EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci Transl Med 6:254ra127
   PubMed Web of Science ®Google Scholar
• Foxman B. (1990). Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80:331–3
   PubMed Web of Science ®Google Scholar
• Foxman B. (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113:5S–13S
   PubMed Web of Science ®Google Scholar
• Foxman B. (2003). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-Month 49:53–70
   PubMed Web of Science ®Google Scholar
• Franco AV. (2005). Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 19:861–73
   PubMed Web of Science ®Google Scholar
• Frank DN, Wilson SS, St Amand AL, Pace NR. (2009). Culture-independent microbiological analysis of foley urinary catheter biofilms. PLoS One 4:e7811
   PubMedGoogle Scholar
• Frendeus B, Godaly G, Hang L, et al. (2000). Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192:881–90
   PubMed Web of Science ®Google Scholar
• Furtado D. (1976). Experimental group B streptococcal infections in mice: hematogenous virulence and mucosal colonization. Infect Immun 13:1315–20
   PubMed Web of Science ®Google Scholar
• Gally DL, Leathart J, Blomfield IC. (1996). Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol 21:725–38
   PubMed Web of Science ®Google Scholar
• Garcia EC, Brumbaugh AR, Mobley HL. (2011). Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79:1225–35
   PubMed Web of Science ®Google Scholar
• Garcia TA, Ventura CL, Smith MA, et al. (2013). Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect Immun 81:99–109
   PubMed Web of Science ®Google Scholar
• Garofalo CK, Hooton TM, Martin SM, et al. (2007). Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun 75:52–60
   PubMed Web of Science ®Google Scholar
• Godaly G, Hang L, Frendeus B, Svanborg C. (2000). Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 165:5287–94
   PubMed Web of Science ®Google Scholar
• Godaly G, Otto G, Burdick MD, et al. (2007). Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int 71:778–86
   PubMed Web of Science ®Google Scholar
• Goller CC, Arshad M, Noah JW, et al. (2014). Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis. PLoS One 9:e96054
   PubMedGoogle Scholar
• Guiton PS, Cusumano CK, Kline KA, et al. (2012). Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob Agents Chemother 56:4738–45
   PubMed Web of Science ®Google Scholar
• Guiton PS, Hung CS, Hancock LE, et al. (2010). Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun 78:4166–75
   PubMed Web of Science ®Google Scholar
• Hadjifrangiskou M, Gu AP, Pinkner JS, et al. (2012). Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol 194:6195–205
   PubMed Web of Science ®Google Scholar
• Hagan EC, Lloyd AL, Rasko DA, et al. (2010). Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6:e1001187
   PubMed Web of Science ®Google Scholar
• Hagan EC, Mobley HL. (2009). Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol 71:79–91
   PubMed Web of Science ®Google Scholar
• Hagberg L, Engberg I, Freter R, et al. (1983). Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 40:273–83
   PubMed Web of Science ®Google Scholar
• Hagberg L, Hull R, Hull S, et al. (1984). Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46:839–44
   PubMed Web of Science ®Google Scholar
• Hagberg L, Jodal U, Korhonen TK. (1981). Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 31:564–70
   PubMed Web of Science ®Google Scholar
• Han Z, Pinkner JS, Ford B, et al. (2010). Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J Med Chem 53:4779–92
   PubMed Web of Science ®Google Scholar
• Hang L, Frendeus B, Godaly G, Svanborg C. (2000). Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 182:1738–48
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Mysorekar IU, Hung CS, et al. (2010). Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6:e1001042
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Roberts PL, Riehl TE, et al. (2014). Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis. EBioMedicine 1:46--57
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Totsika M, Mansfield KJ, et al. (2012). Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36:616–48
   PubMed Web of Science ®Google Scholar
• Hawn TR, Scholes D, Li SS, et al. (2009). Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS ONE 4:e5990
   PubMed Web of Science ®Google Scholar
• Hay AD, Fahey T. (2002). Clinical diagnosis of urinary tract infection. J Am Med Assoc 288:1229; author reply 1230–1
   Google Scholar
• Healy EF, Walsh CA, Cotter AM, Walsh SR. (2012). Suprapubic compared with transurethral bladder catheterization for gynecologic surgery: a systematic review and meta-analysis. Obstet Gynecol 120:678–87
   PubMed Web of Science ®Google Scholar
• Hedges S, Agace W, Svensson M, et al. (1994). Uroepithelial cells are part of a mucosal cytokine network. Infect Immun 62:2315–21
   PubMed Web of Science ®Google Scholar
• Hedges S, Svensson M, Svanborg C. (1992). Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 60:1295–301
   PubMed Web of Science ®Google Scholar
• Hernandez JG, Sunden F, Connolly J, et al. (2011). Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 6:e28289
   PubMed Web of Science ®Google Scholar
• High KP, Bradley SF, Gravenstein S, et al. (2009). Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 48:149–71
   PubMed Web of Science ®Google Scholar
• Hilbert DW, Paulish-Miller TE, Tan CK, et al. (2012). Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 14:628–38
   PubMed Web of Science ®Google Scholar
• Hoelzer K, Pouillot R, Dennis S. (2012). Animal models of listeriosis: a comparative review of the current state of the art and lessons learned. Vet Res 43:18
   PubMed Web of Science ®Google Scholar
• Hoepelman AI, Meiland R, Geerlings SE. (2003). Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 22:35–43
   PubMed Web of Science ®Google Scholar
• Hola V, Peroutkova T, Ruzicka F. (2012). Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections. FEMS Immunol Med Microbiol 65:343–9
   PubMedGoogle Scholar
• Hooton TM, Scholes D, Hughes JP, et al. (1996). A prospective study of risk factors for symptomatic urinary tract infection in young women. New Engl J Med 335:468–74
   PubMed Web of Science ®Google Scholar
• Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. (1998). Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 66:2798–802
   PubMed Web of Science ®Google Scholar
• Hopkins WJ, Hall JA, Conway BP, Uehling DT. (1995). Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J Infect Dis 171:462–5
   PubMed Web of Science ®Google Scholar
• Hopkins WJ, James LJ, Balish E, Uehling DT. (1993). Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection. J Urol 149:922–5
   PubMed Web of Science ®Google Scholar
• Huber M, Krauter K, Winkelmann G, et al. (2000). Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int J Immunopharmacol 22:1103–11
   Google Scholar
• Hughes FM Jr, Vivar NP, Kennis JG, et al. (2014). Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. Am J Physiol Renal Physiol 306: F299–308
   PubMed Web of Science ®Google Scholar
• Hull R, Rudy D, Donovan W, et al. (2000). Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 163:872–7
   PubMed Web of Science ®Google Scholar
• Hung CS, Dodson KW, Hultgren SJ. (2009). A murine model of urinary tract infection. Nat Protocols 4:1230–43
   PubMed Web of Science ®Google Scholar
• Hunstad DA, Justice SS. (2010). Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203–21
   PubMed Web of Science ®Google Scholar
• Hvidberg H, Struve C, Krogfelt KA, et al. (2000). Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother 44:156–63
   PubMed Web of Science ®Google Scholar
• Ichinohe T, Pang IK, Kumamoto Y, et al. (2011). Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 108:5354–9
   PubMed Web of Science ®Google Scholar
• Ingersoll MA, Kline KA, Nielsen HV, Hultgren SJ. (2008). G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol 10:2568–78
   PubMed Web of Science ®Google Scholar
• Ipe DS, Sundac L, Benjamin WH Jr, et al. (2013). Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol Lett 346:1–10
   PubMed Web of Science ®Google Scholar
• Iwahi T, Abe Y, Tsuchiya K. (1982). Virulence of Escherichia coli in ascending urinary-tract infection in mice. J Med Microbiol 15:303–16
   PubMed Web of Science ®Google Scholar
• Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21:26–59
   PubMed Web of Science ®Google Scholar
• Jaillon S, Moalli F, Ragnarsdottir B, et al. (2014). The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity 40:621–32
   PubMed Web of Science ®Google Scholar
• Janssen C, Lo J, Jager W, et al. (2014). A high throughput, minimally invasive, ultrasound guided model for the study of catheter associated urinary tract infections and device encrustation in mice. J Urol 192:1856–63
   PubMed Web of Science ®Google Scholar
• Johansen TE, Botto H, Cek M, et al. (2011). Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents 38:64–70
   PubMed Web of Science ®Google Scholar
• Johnson JR. (1998). Reflux in the mouse model of urinary tract infection. Infect Immun 66:6063–4
   PubMed Web of Science ®Google Scholar
• Johnson JR, Brown JJ. (1996). Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection. J Infect Dis 173:746–9
   PubMed Web of Science ®Google Scholar
• Johnson JR, Clabots C, Rosen H. (2006). Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect Immun 74:461–8
   PubMed Web of Science ®Google Scholar
• Johnson JR, Delavari P, Azar M. (1999). Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother 43:2990–5
   PubMed Web of Science ®Google Scholar
• Johnson JR, Manivel JC. (1991). Vesicoureteral reflux induces renal trauma in a mouse model of ascending, unobstructed pyelonephritis. J Urol 145:1306–11
   PubMed Web of Science ®Google Scholar
• Johnson DE, Lockatell CV, Hall-Craigs M, et al. (1987). Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol 138:632–5
   PubMed Web of Science ®Google Scholar
• Johnson DE, Lockatell CV, Russell RG, et al. (1998). Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect Immun 66:3059–65
   PubMed Web of Science ®Google Scholar
• Johnson DE, Russell RG, Lockatell CV, et al. (1993a). Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with “nonuropathogenic” Escherichia coli. Infect Immun 61:3422–8
   PubMed Web of Science ®Google Scholar
• Johnson DE, Russell RG, Lockatell CV, et al. (1993b). Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun 61:2748–54
   PubMed Web of Science ®Google Scholar
• Jones-Carson J, Balish E, Uehling DT. (1999). Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. J Urol 161:338–41
   PubMed Web of Science ®Google Scholar
• Kai-Larsen Y, Luthje P, Chromek M, et al. (2010). Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6:e1001010
   PubMed Web of Science ®Google Scholar
• Kalmanson GM, Harwick HJ, Turck M, Guze LB. (1975). Urinary-tract infection: localisation and virulence of Escherichia coli. Lancet 1:134–6
   PubMed Web of Science ®Google Scholar
• Kaufmann J, Modest GA. (2002). Clinical diagnosis of urinary tract infection. J Am Med Assoc 288:1229–30; author reply 1230–1
   Google Scholar
• Kaul AK, Khan S, Martens MG, et al. (1999). Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice. Infect Immun 67:5958–66
   PubMed Web of Science ®Google Scholar
• Kemp KD, Singh KV, Nallapareddy SR, Murray BE. (2007). Relative contributions of Enterococcus faecalis OG1RF sortase-encoding genes, srtA and bps (srtC), to biofilm formation and a murine model of urinary tract infection. Infect Immun 75:5399–404
   PubMed Web of Science ®Google Scholar
• Kline KA, Schwartz DJ, Gilbert NM, et al. (2012). Immune modulation by group B streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun 80:4186–94
   PubMed Web of Science ®Google Scholar
• Kline KA, Schwartz DJ, Gilbert NM, Lewis AL. (2014). Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. PLoS One 9:e97798
   PubMedGoogle Scholar
• Kline KA, Schwartz DJ, Lewis WG, et al. (2011). Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect Immun 79:3588–95
   PubMed Web of Science ®Google Scholar
• Ko YC, Mukaida N, Ishiyama S, et al. (1993). Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 61:1307–14
   PubMed Web of Science ®Google Scholar
• Kostakioti M, Hadjifrangiskou M, Cusumano CK, et al. (2012). Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826–34
   PubMed Web of Science ®Google Scholar
• Koves B, Salvador E, Gronberg-Hernandez J, et al. (2014). Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoire. J Urol 191:519–28
   PubMed Web of Science ®Google Scholar
• Kunin CM. (1994). Urinary tract infections in females. Clin Infect Dis 18:1–10; quiz 11–12
   PubMed Web of Science ®Google Scholar
• Lane MC, Alteri CJ, Smith SN, Mobley HL. (2007). Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natil Acad Sci USA 104:16669–74
   PubMed Web of Science ®Google Scholar
• Lane MC, Lockatell V, Monterosso G, et al. (2005). Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 73:7644–56
   PubMed Web of Science ®Google Scholar
• Langermann S, Palaszynski S, Barnhart M, et al. (1997). Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276:607–11
   PubMed Web of Science ®Google Scholar
• Lee JBL, Neild GH. (2007). Urinary tract infection. Medicine 35:423–8
   Google Scholar
• Lefort A, Chau F, Lepeule R, et al. (2014). Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum beta-lactamase. Int J Antimicrob Agents 43:366–9
   PubMed Web of Science ®Google Scholar
• Li CR, Li Y, Li GQ, et al. (2010). In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. J Antimicrob Chemother 65:2411–15
   PubMed Web of Science ®Google Scholar
• Li X, Zhao H, Lockatell CV, et al. (2002). Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun 70:389–94
   PubMed Web of Science ®Google Scholar
• Louz D, Bergmans HE, Loos BP, Hoeben RC. (2013). Animal models in virus research: their utility and limitations. Crit Rev Microbiol 39:325–61
   PubMed Web of Science ®Google Scholar
• Maki DG, Tambyah PA. (2001). Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7:342–7
   PubMed Web of Science ®Google Scholar
• Mastroeni P, Sheppard M. (2004). Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 6:398–405
   PubMed Web of Science ®Google Scholar
• Mcbean M, Rajamani S. (2001). Increasing rates of hospitalization due to septicemia in the US elderly population, 1986–1997. J Infect Dis 183:596–603
   PubMed Web of Science ®Google Scholar
• Meddings J, Rogers MA, Macy M, Saint S. (2010). Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis 51:550–60
   PubMed Web of Science ®Google Scholar
• Mobley HL, Green DM, Trifillis AL, et al. (1990). Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58:1281–9
   PubMed Web of Science ®Google Scholar
• Mobley HL, Jarvis KG, Elwood JP, et al. (1993). Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1–4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol 10:143–55
   PubMed Web of Science ®Google Scholar
• Moriel DG, Schembri MA. (2013). Vaccination approaches for the prevention of urinary tract infection. Curr Pharm Biotechnol 14:967–74
   PubMed Web of Science ®Google Scholar
• Morin MD, Hopkins WJ. (1998). Treatment of mice with staphylococcal enterotoxin B enhances resolution of an induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines. Infect Immun 66:2466–70
   PubMed Web of Science ®Google Scholar
• Mulvey MA. (2002). Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 4:257–71
   PubMed Web of Science ®Google Scholar
• Mulvey MA, Schilling JD, Hultgren SJ. (2001). Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572–9
   PubMed Web of Science ®Google Scholar
• Murphy CN, Mortensen MS, Krogfelt KA, Clegg S. (2013). Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect Immun 81:3009–17
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Casadevall A, Ausubel FM. (2007). Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 3:e101
   PubMed Web of Science ®Google Scholar
• Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI. (2002). Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 277:7412–19
   PubMed Web of Science ®Google Scholar
• Natarajan V. (2008). Urinary tract infection. Surgery (Oxford) 26:193–6
   Google Scholar
• Neild GH. (2003). Urinary tract infection. Medicine (Abingdon) 31:85–90
   Google Scholar
• Ness-Schwickerath KJ, Morita CT. (2011). Regulation and function of IL-17A- and IL-22-producing gammadelta T cells. Cell Mol Life Sci 68:2371–90
   PubMed Web of Science ®Google Scholar
• Nesta B, Spraggon G, Alteri C, et al. (2012). FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio 3:e00010–12
   Google Scholar
• Nicholson AM, Glynn AA. (1975). Investigation of the effect of K antigen in Escherichia coli urinary tract infections by use of a mouse model. Br J Exp Pathol 56:549–53
   PubMedGoogle Scholar
• Nicolle LE. (2008). Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 35:1–12, v
   PubMed Web of Science ®Google Scholar
• Nicolle LE. (2014). Catheter associated urinary tract infections. Antimicrob Resist Infect Control 3:23--30
   PubMed Web of Science ®Google Scholar
• Nielsen HV, Guiton PS, Kline KA, et al. (2012). The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection. MBio 3:e00177–12
   Web of Science ®Google Scholar
• Nielsen KL, Dynesen P, Larsen P, et al. (2014). Role of urinary cathelicidin LL-37 and human beta-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect Immun 82:1572–8
   PubMed Web of Science ®Google Scholar
• Nielubowicz GR, Mobley HL. (2010). Host–pathogen interactions in urinary tract infection. Nat Rev Urol 7:430–41
   PubMed Web of Science ®Google Scholar
• O'Hanley P, Lark D, Falkow S, Schoolnik G. (1985). Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal–Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest 75:347–60
   PubMed Web of Science ®Google Scholar
• Oh JZ, Ravindran R, Chassaing B, et al. (2014). TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41:478–92
   PubMed Web of Science ®Google Scholar
• Olson PD, Hunstad DA. (2014). A new model of urinary tract infection reveals male susceptibility to chronic cystitis and severe pyelonephritis. American Society for Microbiology, 114th General Meeting. Boston, USA
   Google Scholar
• Ong CL, Ulett GC, Mabbett AN, et al. (2008). Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol 190:1054–63
   PubMed Web of Science ®Google Scholar
• Pang IK, Iwasaki A. (2012). Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 245:209–26
   PubMed Web of Science ®Google Scholar
• Pearson MM, Yep A, Smith SN, Mobley HL. (2011). Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun 79:2619–31
   PubMed Web of Science ®Google Scholar
• Pecha B, Low D, O'Hanley P. (1989). Gal–Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal–Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains. J Clin Invest 83:2102–8
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Galvalisi U, Scavone P, et al. (2003). Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol Med Microbiol 36:103–10
   PubMedGoogle Scholar
• Press MJ, Metlay JP. (2013). Catheter-associated urinary tract infection: does changing the definition change quality? Infect Control Hosp Epidemiol 34:313–15
   PubMed Web of Science ®Google Scholar
• Raffi HS, Bates JM Jr, Laszik Z, Kumar S. (2005). Tamm–Horsfall protein acts as a general host-defense factor against bacterial cystitis. Am J Nephrol 25:570–8
   PubMed Web of Science ®Google Scholar
• Raffi HS, Bates JM Jr, Laszik Z, Kumar S. (2009). Tamm–Horsfall protein protects against urinary tract infection by Proteus mirabilis. J Urol 181:2332–8
   PubMed Web of Science ®Google Scholar
• Ragnarsdottir B, Fischer H, Godaly G, et al. (2008). TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest 38:12–20
   PubMed Web of Science ®Google Scholar
• Ragnarsdottir B, Jonsson K, Urbano A, et al. (2010). Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5:e10734
   PubMed Web of Science ®Google Scholar
• Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, et al. (2011). Genetics of innate immunity and UTI susceptibility. Nat Rev Urol 8:449–68
   PubMed Web of Science ®Google Scholar
• Ragnarsdottir B, Samuelsson M, Gustafsson MC, et al. (2007). Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 196:475–84
   PubMed Web of Science ®Google Scholar
• Raz R, Gennesin Y, Wasser J, et al. (2000). Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 30:152–6
   PubMed Web of Science ®Google Scholar
• Reigstad CS, Hultgren SJ, Gordon JI. (2007). Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 282:21259–67
   PubMed Web of Science ®Google Scholar
• Robino L, Scavone P, Araujo L, et al. (2013). Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog Dis 68:78–81
   PubMed Web of Science ®Google Scholar
• Robino L, Scavone P, Araujo L, et al. (2014). Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin Infect Dis 59:e158--64
   PubMed Web of Science ®Google Scholar
• Roelofs JJ, Rouschop KM, Teske GJ, et al. (2006). The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis. Kidney Int 70:1942–7
   PubMed Web of Science ®Google Scholar
• Ronald A. (2002). The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113:14S–19S
   PubMed Web of Science ®Google Scholar
• Ronald A. (2003). The etiology of urinary tract infection: traditional and emerging pathogens. Disease-a-Month 49:71–82
   PubMed Web of Science ®Google Scholar
• Roos V, Klemm P. (2006). Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 74:3565–75
   PubMed Web of Science ®Google Scholar
• Roos V, Ulett GC, Schembri MA, Klemm P. (2006). The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 74:615–24
   PubMed Web of Science ®Google Scholar
• Rosen DA, Hooton TM, Stamm WE, et al. (2007). Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4:e329
   PubMed Web of Science ®Google Scholar
• Rosen DA, Hung CS, Kline KA, Hultgren SJ. (2008). Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun 76:4290–8
   PubMed Web of Science ®Google Scholar
• Rudick CN, Billips BK, Pavlov VI, et al. (2010). Host–pathogen interactions mediating pain of urinary tract infection. J Infect Dis 201:1240–9
   PubMed Web of Science ®Google Scholar
• Russo T, Brown JJ, Jodush ST, Johnson JR. (1996a). The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli. Infect Immun 64:2343–8
   PubMed Web of Science ®Google Scholar
• Russo TA, Jodush ST, Brown JJ, Johnson JR. (1996b). Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol 22:217–29
   PubMed Web of Science ®Google Scholar
• Russo TA, Mcfadden CD, Carlino-Macdonald UB, et al. (2003). The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71:7164–9
   PubMed Web of Science ®Google Scholar
• Sabri M, Houle S, Dozois CM. (2009). Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection. Infect Immun 77:1155–64
   PubMed Web of Science ®Google Scholar
• Saemann MD, Weichhart T, Zeyda M, et al. (2005). Tamm–Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a toll-like receptor-4-dependent mechanism. J Clin Invest 115:468–75
   PubMed Web of Science ®Google Scholar
• Salvatore S, Salvatore S, Cattoni E, et al. (2011). Urinary tract infections in women. Eur J Obstet Gynecol Reproduct Biol 156:131–6
   PubMed Web of Science ®Google Scholar
• Savidge TC, Morey AL, Ferguson DJ, et al. (1995). Human intestinal development in a severe-combined immunodeficient xenograft model. Differentiation 58:361–71
   PubMed Web of Science ®Google Scholar
• Scavone P, Umpierrez A, Rial A, et al. (2014). Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein. Anton van Leeuw 105:1139–48
   PubMed Web of Science ®Google Scholar
• Schembri MA, Sokurenko EV, Klemm P. (2000). Functional flexibility of the FimH adhesin: insights from a random mutant library. Infect Immun 68:2638–46
   PubMed Web of Science ®Google Scholar
• Schilling JD, Lorenz RG, Hultgren SJ. (2002). Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70:7042–9
   PubMed Web of Science ®Google Scholar
• Schilling JD, Martin SM, Hung CS, et al. (2003). Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci USA 100:4203–8
   PubMed Web of Science ®Google Scholar
• Schilling JD, Mulvey MA, Hultgren SJ. (2001a). Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57:56–61
   PubMed Web of Science ®Google Scholar
• Schilling JD, Mulvey MA, Vincent CD, et al. (2001b). Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol 166:1148–55
   PubMed Web of Science ®Google Scholar
• Schmidt MA, O'Hanley P, Lark D, Schoolnik GK. (1988). Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model. Proc Natl Acad Sci USA 85:1247–51
   PubMed Web of Science ®Google Scholar
• Schneeberger C, Kazemier BM, Geerlings SE. (2014). Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis 27:108–14
   PubMed Web of Science ®Google Scholar
• Scholes D, Hooton TM, Roberts PL, et al. E. (2000). Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182:1177–82
   PubMed Web of Science ®Google Scholar
• Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ. (2015). Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog 11:e1004599
   PubMed Web of Science ®Google Scholar
• Seok J, Warren HS, Cuenca AG, et al. (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507–12
   PubMed Web of Science ®Google Scholar
• Shankar N, Lockatell CV, Baghdayan AS, et al. (2001). Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 69:4366–72
   PubMed Web of Science ®Google Scholar
• Sidjabat HE, Chin JJ, Chapman T, et al. (2009). Colonisation dynamics and virulence of two clonal groups of multidrug-resistant Escherichia coli isolated from dogs. Microbes Infect 11:100–7
   PubMed Web of Science ®Google Scholar
• Siegman-Igra Y, Fourer B, Orni-Wasserlaufr R, et al. (2002). Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 34:1431–9
   PubMed Web of Science ®Google Scholar
• Sillanpaa J, Nallapareddy SR, Singh KV, et al. (2010). Characterization of the ebp(fm) pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection. Virulence 1:236–46
   PubMed Web of Science ®Google Scholar
• Silva TM, Costa EA, Paixao TA, et al. (2011). Laboratory animal models for brucellosis research. J Biomed Biotechnol 2011:518323
   PubMed Web of Science ®Google Scholar
• Singh KV, Nallapareddy SR, Murray BE. (2007). Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J Infect Dis 195:1671–7
   PubMed Web of Science ®Google Scholar
• Sivick KE, Mobley HL. (2010). Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78:568–85
   PubMed Web of Science ®Google Scholar
• Sivick KE, Schaller MA, Smith SN, Mobley HL. (2010). The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol 184:2065–75
   PubMed Web of Science ®Google Scholar
• Smithson A, Sarrias MR, Barcelo J, et al. (2005). Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin Diagn Lab Immunol 12:1358–63
   PubMedGoogle Scholar
• Snyder JA, Haugen BJ, Buckles EL, et al. (2004). Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72:6373–81
   PubMed Web of Science ®Google Scholar
• Song J, Abraham SN. (2008). TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol 11:66–73
   PubMed Web of Science ®Google Scholar
• Springall T, Sheerin NS, Abe K, et al. (2001). Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 7:801–6
   PubMed Web of Science ®Google Scholar
• Stahlhut SG, Struve C, Krogfelt KA, Reisner A. (2012). Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol 65:350–9
   PubMed Web of Science ®Google Scholar
• Stamm WE. (2006). Theodore E. Woodward Award: host–pathogen interactions in community-acquired urinary tract infections. Trans Am Clin Climatol Assoc 117:75–83; discussion 83–4
   PubMedGoogle Scholar
• Stamm WE, Hooton TM. (1993). Management of urinary tract infections in adults. New Engl J Med 329:1328–34
   PubMed Web of Science ®Google Scholar
• Stamm WE, Norrby SR. (2001). Urinary tract infections: disease panorama and challenges. J Infect Dis 183:S1–4
   Web of Science ®Google Scholar
• Stapleton A. (1999). Prevention of recurrent urinary-tract infections in women. Lancet 353:7–8
   PubMed Web of Science ®Google Scholar
• Subashchandrabose S, Hazen TH, Brumbaugh AR, et al. (2014). Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc Natl Acad Sci USA 111:18327–32
   PubMed Web of Science ®Google Scholar
• Sunden F, Hakansson L, Ljunggren E, Wullt B. (2010). Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol 184:179–85
   PubMed Web of Science ®Google Scholar
• Svanborg C, Bergsten G, Fischer H, et al. (2001). The ‘innate’ host response protects and damages the infected urinary tract. Ann Med 33:563–70
   PubMed Web of Science ®Google Scholar
• Svanborg Eden C, Briles D, Hagberg L, et al. (1985). Genetic factors in host resistance to urinary tract infection. Infection 13:S171–6
   PubMed Web of Science ®Google Scholar
• Svensson M, Yadav M, Holmqvist B, et al. (2011). Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice. Kidney Int 80:1064–72
   PubMed Web of Science ®Google Scholar
• Tabibian JH, Gornbein J, Heidari A, et al. (2008). Uropathogens and host characteristics. J Clin Microbiol 46:3980–6
   PubMed Web of Science ®Google Scholar
• Tan CK, Carey AJ, Cui X, et al. (2012a). Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. Infect Immun 80:3145–60
   PubMed Web of Science ®Google Scholar
• Tan CK, Ulett KB, Steele M, et al. (2012b). Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients. BMC Infect Dis 12:273
   PubMedGoogle Scholar
• Tena D, Gonzalez-Praetorius A, Bisquert J. (2007). Urinary tract infection due to non-typhoidal Salmonella: report of 19 cases. J Infect 54:245–9
   PubMed Web of Science ®Google Scholar
• Tenke P, Koves B, Johansen TE. (2014). An update on prevention and treatment of catheter-associated urinary tract infections. Curr Opin Infect Dis 27:102–7
   PubMed Web of Science ®Google Scholar
• Thai KH, Thathireddy A, Hsieh MH. (2010). Transurethral induction of mouse urinary tract infection. J Vis Exp 42:pii2070
   Google Scholar
• Totsika M, Beatson SA, Sarkar S, et al. (2011). Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6:e26578
   PubMed Web of Science ®Google Scholar
• Totsika M, Heras B, Wurpel DJ, Schembri MA. (2009). Characterization of two homologous disulfide bond systems involved in virulence factor biogenesis in uropathogenic Escherichia coli CFT073. J Bacteriol 191:3901–8
   PubMed Web of Science ®Google Scholar
• Totsika M, Kostakioti M, Hannan TJ, et al. (2013). A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J Infect Dis 208:921–8
   PubMed Web of Science ®Google Scholar
• Tratselas A, Simitsopoulou M, Giannakopoulou A, et al. (2014). Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 58:7102–11
   PubMed Web of Science ®Google Scholar
• Trautner BW. (2010). Management of catheter-associated urinary tract infection. Curr Opin Infect Dis 23:76–82
   PubMed Web of Science ®Google Scholar
• Trautner BW, Hull RA, Darouiche RO. (2005). Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis 18:37–41
   PubMed Web of Science ®Google Scholar
• Tree JJ, Ulett GC, Ong CL, et al. (2008). Trade-off between iron uptake and protection against oxidative stress: deletion of cueO promotes uropathogenic Escherichia coli virulence in a mouse model of urinary tract infection. J Bacteriol 190:6909–12
   PubMed Web of Science ®Google Scholar
• Tsuji M, Takema M, Miwa H, et al. (2003). In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrob Agents Chemother 47:2507–12
   PubMed Web of Science ®Google Scholar
• Ulett KB, Benjamin WH Jr, Zhuo F, et al. (2009). Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol 47:2055–60
   PubMed Web of Science ®Google Scholar
• Ulett KB, Shuemaker JH, Benjamin WH Jr, et al. (2012). Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report. J Med Case Rep 6:237–40
   PubMedGoogle Scholar
• Ulett GC, Totsika M, Schaale K, et al. (2013). Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16:100–7
   PubMed Web of Science ®Google Scholar
• Ulett GC, Valle J, Beloin C, et al. (2007). Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233–44
   PubMed Web of Science ®Google Scholar
• Ulett GC, Webb RI, Ulett KB, et al. (2010). Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha. J Infect Dis 201:866–70
   PubMed Web of Science ®Google Scholar
• Umpierrez A, Scavone P, Romanin D, et al. (2013). Innate immune responses to Proteus mirabilis flagellin in the urinary tract. Microbes Infect 15:688–96
   PubMed Web of Science ®Google Scholar
• Van Duin D. (2012). Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis 54:973–8
   PubMed Web of Science ®Google Scholar
• Vebo HC, Solheim M, Snipen L, et al. (2010). Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine. PLoS One 5:e12489
   PubMedGoogle Scholar
• Vimont S, Boyd A, Bleibtreu A, et al. (2012). The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547
   PubMedGoogle Scholar
• Vivaldi E. (1968). Effect of chronic administration of analgesics on resistance to experimental infection of the urinary tract in rats. Nephron 5:202–9
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Naber KG. (2004). Emergence of antibiotic resistance and prudent use of antibiotic therapy in nosocomially acquired urinary tract infections. Int J Antimicrob Agents 23:S24–9
   PubMed Web of Science ®Google Scholar
• Wang C, Symington JW, Ma E, et al. (2013). Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model. Infect Immun 81:733–9
   PubMed Web of Science ®Google Scholar
• Wang C, Yuan X, Ma E, et al. (2014). NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection. Autophagy 10:331–8
   PubMed Web of Science ®Google Scholar
• Warren JW, Tenney JH, Hoopes JM, et al. (1982). A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146:719–23
   PubMed Web of Science ®Google Scholar
• Watts RE, Tan CK, Ulett GC, et al. (2012a). Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coli. J Infect Dis 206:1242–9
   PubMed Web of Science ®Google Scholar
• Watts RE, Totsika M, Challinor VL, et al. (2012b). Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect Immun 80:333–44
   PubMed Web of Science ®Google Scholar
• Wieser A, Romann E, Magistro G, et al. (2010). A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect Immun 78:3432–42
   PubMed Web of Science ®Google Scholar
• Wobser D, Ali L, Grohmann E, et al. (2014). A novel role for D-alanylation of lipoteichoic acid of Enterococcus faecalis in urinary tract infection. PLoS One 9: e107827
   PubMed Web of Science ®Google Scholar
• Wu XR, Sun TT, Medina JJ. (1996). In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci USA 93:9630–5
   PubMed Web of Science ®Google Scholar
• Wullt B. (2003). The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 21:605–21
   PubMedGoogle Scholar
• Wullt B, Bergsten G, Connell H, et al. (2001). P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3:255–64
   PubMed Web of Science ®Google Scholar
• Wullt B, Bergsten G, Fischer H, et al. (2003). The host response to urinary tract infection. Infect Dis Clin North Am 17:279–301
   PubMed Web of Science ®Google Scholar
• Wullt B, Bergsten G, Samuelsson M, Svanborg C. (2002). The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 19:522–38
   PubMed Web of Science ®Google Scholar
• Wullt B, Connell H, Rollano P, et al. (1998). Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J Urol 159:2057–62
   PubMed Web of Science ®Google Scholar
• Yadav M, Zhang J, Fischer H, et al. (2010). Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog 6:e1001120
   PubMed Web of Science ®Google Scholar
• Yin X, Hou T, Liu Y, et al. (2010). Association of toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS One 5:e14223
   PubMedGoogle Scholar
• You XF, Li CR, Yang XY, et al. (2009). In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother 53:4525–8
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jin L, Champion G, et al. (2001). Shigella infection in a SCID mouse–human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine. Infect Immun 69:3240–7
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang G, Hayden MS, et al. (2004). A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522–6
   PubMed Web of Science ®Google Scholar